Evaluation the stop-bleeding effect of Sandostanin in gastroduodenal ulcer-caused hemorrhage

ABSTRACT

The study involved 30 patients (21 males, 9 females, aged from 18 to 77) who had gastroduodenal ulcer-caused bleeding at the Hospital 103 between October 1999 to July 2000. Common symptoms included dizziness, tar-like stool, fatigue and fast pulse. The patients received Sandostanin 0.1 mg two ampoule mixed in 500 ml isotonic glucose or saline solution intravenous for 4 - 5 hours in consecutive 3 days. Results: Sandostanin (octreotid) is effective for gastroduodenal ulcer-caused bleeding, stops bleeding rapidly even in first day (93.4%), reduce the amount of transfused blood, shorten the stay duration, reduce the relapse, rate of induced sclerotization and operation is lowered. Sandostanin is safe, almost free of adverse effects and should be indicated early.